CNS Pharmaceuticals (CNSP) Price-to-Earnings (P/E) Ratio
Price: $1.085
Market Cap: $3.19M
Avg Volume: 529.34K
Market Cap: $3.19M
Avg Volume: 529.34K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
CNS Pharmaceuticals's P/E ratios across different time periods:
- TTM: -0.10
- Annual: -0.15
- Quarterly: -0.67
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 0.37
- Price-to-Sales (P/S) Ratio: 0.00
Annual Ratios
CNS Pharmaceuticals Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-0.10
P/B Ratio (Annual)
0.37
P/S Ratio (Annual)
0.00
CNS Pharmaceuticals Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -0.15 | 0.37 | 0.00 |
| 2023 | -12.63 | -53.73 | 0.00 |
| 2022 | -10698.48 | 20092.57 | 0.00 |
| 2021 | -61783.21 | 135243.81 | 0.00 |
| 2020 | -155267.50 | 105284.03 | 0.00 |
| 2019 | -837890.30 | 427397.06 | 0.00 |
| 2018 | -508475.09 | -6842545.39 | 0.00 |
| 2017 | -7139255.11 | -64214387.00 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for CNSP.